In Silico and in Vitro Screening for P-Glycoprotein Interaction with Tenofovir, Darunavir, and Dapivirine: An Antiretroviral Drug Combination for Topical Prevention of …

M Swedrowska, S Jamshidi, A Kumar… - Molecular …, 2017 - ACS Publications
The aim of the study was to use in silico and in vitro techniques to evaluate whether a triple
formulation of antiretroviral drugs (tenofovir, darunavir, and dapivirine) interacted with P …
被引用次数：14 相关文章

In Silico and in Vitro Screening for P-Glycoprotein Interaction with Tenofovir, Darunavir, and Dapivirine: An Antiretroviral Drug Combination for Topical Prevention of …

M Swedrowska, S Jamshidi, A Kumar… - Molecular …, 2017 - pubmed.ncbi.nlm.nih.gov
The aim of the study was to use in silico and in vitro techniques to evaluate whether a triple
formulation of antiretroviral drugs (tenofovir, darunavir, and dapivirine) interacted with P …

In Silico and in Vitro Screening for P-Glycoprotein Interaction with Tenofovir, Darunavir, and Dapivirine: An Antiretroviral Drug Combination for Topical Prevention of …

M Swedrowska, S Jamshidi, A Kumar… - Molecular …, 2017 - europepmc.org
The aim of the study was to use in silico and in vitro techniques to evaluate whether a triple
formulation of antiretroviral drugs (tenofovir, darunavir, and dapivirine) interacted with P …

In Silico and in Vitro Screening for P-Glycoprotein Interaction with Tenofovir, Darunavir, and Dapivirine: An Antiretroviral Drug Combination for Topical Prevention of …

M Swedrowska, S Jamshidi, A Kumar… - Molecular …, 2017 - kclpure.kcl.ac.uk
The aim of the study was to use in silico and in vitro techniques to evaluate whether a triple
formulation of antiretroviral drugs (tenofovir, darunavir, and dapivirine) interacted with P …